Advertisement

Payer

Advertisement

Payer-provider conflicts, payer finances and an antitrust trial involving two of the nation's five largest health insurers most captured the attention of Becker's Hospital Review readers in 2016.

Interpace Diagnostics, a diagnostic testing and pathology services provider, agreed to participate in the Blue Cross Blue Shield Association's Center for Clinical Effectiveness program "Evidence Street."

Blue Cross Blue Shield of Texas and Arlington-based Texas Health Resources agreed to renew a contract that had been in dispute over a proposed rate increase by the health system and disagreement over the language of a termination clause, according…

Advertisement